• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding.

作者信息

Frank Annabel K, Ganesan Previn, Thompson Ashley, Fang Margaret C

机构信息

Department of Medicine, University of California, San Francisco, United States of America.

Department of Medicine, University of California, San Francisco, United States of America.

出版信息

Thromb Res. 2021 Feb;198:132-134. doi: 10.1016/j.thromres.2020.11.037. Epub 2020 Dec 8.

DOI:10.1016/j.thromres.2020.11.037
PMID:33326909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867603/
Abstract
摘要

相似文献

1
Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding.凝血酶原复合物浓缩剂用于Xa因子抑制剂相关出血的应用及结果
Thromb Res. 2021 Feb;198:132-134. doi: 10.1016/j.thromres.2020.11.037. Epub 2020 Dec 8.
2
Outcomes Associated With 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients.4 因子凝血酶原复合物浓缩物用于逆转出血患者口服 Xa 因子抑制剂的相关结局。
J Clin Pharmacol. 2021 May;61(5):598-605. doi: 10.1002/jcph.1779. Epub 2020 Nov 9.
3
Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.四种凝血因子浓缩物（4F-PCC）治疗因子 Xa 抑制剂相关出血患者的安全性、疗效和成本：一项回顾性研究。
J Thromb Thrombolysis. 2019 Aug;48(2):250-255. doi: 10.1007/s11239-019-01846-5.
4
Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis.Andexanet Alfa 或凝血酶原复合物浓缩物逆转急性大出血时的因子 Xa 抑制剂：系统评价和荟萃分析。
Crit Care Med. 2021 Oct 1;49(10):e1025-e1036. doi: 10.1097/CCM.0000000000005059.
5
Prothrombin Complex Concentrate Should Be Used to Reverse Factor Xa Inhibitors in the Setting of Life-Threatening Bleeding.
Ann Emerg Med. 2023 Sep;82(3):362-363. doi: 10.1016/j.annemergmed.2022.09.003. Epub 2023 Jan 18.
6
Clinical experience reversing factor Xa inhibitors with four-factor prothrombin complex concentrate in a community hospital.在一家社区医院使用四因子凝血酶原复合物浓缩物逆转Xa因子抑制剂的临床经验。
Blood Transfus. 2018 Jul;16(4):382-386. doi: 10.2450/2017.0219-16. Epub 2017 Jan 24.
7
Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor-associated major bleeding.循证迷你评论：接受凝血酶原复合物浓缩物或andexanet alfa 治疗直接口服因子 Xa 抑制剂相关大出血患者的死亡率和血栓形成。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):204-208. doi: 10.1182/hematology.2019000074.
8
Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate.四因子凝血酶原复合物浓缩物对口服 Xa 因子抑制剂的紧急逆转作用。
Am J Emerg Med. 2020 Dec;38(12):2641-2645. doi: 10.1016/j.ajem.2020.08.019. Epub 2020 Aug 19.
9
Probable pulmonary embolism with repeat administration of prothrombin complex concentrate in a factor Xa inhibitor patient.在一名使用Xa因子抑制剂的患者中，重复给予凝血酶原复合物浓缩剂后可能发生肺栓塞。
J Clin Pharm Ther. 2018 Dec;43(6):903-905. doi: 10.1111/jcpt.12719. Epub 2018 Jun 9.
10
Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study.使用包括andexanet alfa和四因子凝血酶原复合物浓缩物在内的逆转或替代药物对口服Xa因子抑制剂相关出血进行的真实世界管理：一项多中心研究。
Future Cardiol. 2021 Jan;17(1):127-135. doi: 10.2217/fca-2020-0073. Epub 2020 Jul 3.

引用本文的文献

1
Perioperative Antithrombotic Management During Gastroenterological Surgery in Patients With Thromboembolic Risks: Current Status and Future Prospects.血栓栓塞风险患者胃肠外科手术围手术期抗栓管理：现状与未来展望
Cureus. 2022 Mar 24;14(3):e23471. doi: 10.7759/cureus.23471. eCollection 2022 Mar.

本文引用的文献

1
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products.使用凝血酶原复合物浓缩物产品治疗接受阿哌沙班或利伐沙班治疗的颅内出血成人患者。
J Thromb Thrombolysis. 2021 Jan;51(1):151-158. doi: 10.1007/s11239-020-02154-z.
2
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.阿哌沙班治疗与癌症相关的静脉血栓栓塞症。
N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29.
3
Specific Antidotes for Direct Oral Anticoagulant Reversal: Case Closed or Cold Case?直接口服抗凝剂逆转的特异性解毒剂：结案还是悬案？
Circulation. 2019 Oct 29;140(18):1445-1447. doi: 10.1161/CIRCULATIONAHA.119.041687. Epub 2019 Oct 28.
4
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.阿哌沙班与达肝素治疗活动性恶性肿瘤相关静脉血栓栓塞症：ADAM VTE试验
J Thromb Haemost. 2020 Feb;18(2):411-421. doi: 10.1111/jth.14662. Epub 2019 Nov 28.
5
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.口服抗凝药物治疗慢性肾脏病的获益和危害：系统评价和荟萃分析。
Ann Intern Med. 2019 Aug 6;171(3):181-189. doi: 10.7326/M19-0087. Epub 2019 Jul 16.
6
Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.四种凝血因子浓缩物（4F-PCC）治疗因子 Xa 抑制剂相关出血患者的安全性、疗效和成本：一项回顾性研究。
J Thromb Thrombolysis. 2019 Aug;48(2):250-255. doi: 10.1007/s11239-019-01846-5.
7
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.依达赛珠单抗治疗与因子 Xa 抑制剂相关出血的完整研究报告。
N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7.
8
Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis.应用凝血酶原复合物治疗直接因子 Xa 抑制剂相关大出血的管理：一项荟萃分析。
Blood Adv. 2019 Jan 22;3(2):158-167. doi: 10.1182/bloodadvances.2018024133.
9
Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH.主要出血管理有效性评估：有效止血的拟议定义：来自国际血栓与止血学会（ISTH）科学与标准化委员会（SSC）的通讯
J Thromb Haemost. 2016 Jan;14(1):211-4. doi: 10.1111/jth.13148. Epub 2015 Oct 27.
10
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.非手术患者抗止血药品临床研究中严重出血的定义。
J Thromb Haemost. 2005 Apr;3(4):692-4. doi: 10.1111/j.1538-7836.2005.01204.x.